@inproceedings{inproceedings, title  = {{Intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for macular oedema due to central retinal vein occlusion : a within trial cost-utility analysis}},

 publisher = {{Elsevier}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/155211 https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/94953 }},

 year = {{2019}},

 month = {{11}},

 author = {{Flight L and Alshreef A and Hykin PG and Sivaprasad S and Pennington B and Kelly J and Murphy CL and Brazier JE}},

 doi = {{10.1016/j.jval.2019.09.1396}},

 volume = {{22}},

 journal = {{Value in Health}},

 issue = {{Suppl 3}},

 pages = {{S664-S664}},

 note = {{Accessed on 2025/11/29}}}